A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease
Clinical trial NCT00297362 · COMPLETED
Trial details
- NCT number
- NCT00297362
- Sponsor
- Janssen Cilag Pharmaceutica S.A.C.I., Greece
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2004-06-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.